These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10162421)

  • 1. Modelling valuations for health states: the effect of duration.
    Dolan P
    Health Policy; 1996 Dec; 38(3):189-203. PubMed ID: 10162421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregating health state valuations.
    Dolan P
    J Health Serv Res Policy; 1997 Jul; 2(3):160-5; discussion 166-7. PubMed ID: 10180377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time preference, duration and health state valuations.
    Dolan P; Gudex C
    Health Econ; 1995; 4(4):289-99. PubMed ID: 8528431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-life valuations of advanced breast cancer by New Zealand women.
    Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
    Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age on health state valuations.
    Dolan P
    J Health Serv Res Policy; 2000 Jan; 5(1):17-21. PubMed ID: 10787582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling valuations for EuroQol health states.
    Dolan P
    Med Care; 1997 Nov; 35(11):1095-108. PubMed ID: 9366889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuing health status using VAS and TTO: what lies behind the numbers?
    Robinson A; Dolan P; Williams A
    Soc Sci Med; 1997 Oct; 45(8):1289-97. PubMed ID: 9381241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
    Yusof FA; Goh A; Azmi S
    Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To what extent can we explain time trade-off values from other information about respondents?
    Dolan P; Roberts J
    Soc Sci Med; 2002 Mar; 54(6):919-29. PubMed ID: 11996025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling valuations for Eq-5d health states: an alternative model using differences in valuations.
    Dolan P; Roberts J
    Med Care; 2002 May; 40(5):442-6. PubMed ID: 11961478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuations of EQ-5D health states: are the United States and United Kingdom different?
    Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
    Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health state valuations from the general public using the visual analogue scale.
    Gudex C; Dolan P; Kind P; Williams A
    Qual Life Res; 1996 Dec; 5(6):521-31. PubMed ID: 8993098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The time trade-off method: results from a general population study.
    Dolan P; Gudex C; Kind P; Williams A
    Health Econ; 1996; 5(2):141-54. PubMed ID: 8733106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies.
    Shah K; Mulhern B; Longworth L; Janssen MF
    Value Health; 2016 Jan; 19(1):53-9. PubMed ID: 26797236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-method approach to measuring health-state valuations.
    Salomon JA; Murray CJ
    Health Econ; 2004 Mar; 13(3):281-90. PubMed ID: 14981652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe.
    Golicki D; Jakubczyk M; Niewada M; Wrona W; Busschbach JJ
    Value Health; 2010; 13(2):289-97. PubMed ID: 19744296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inconsistency and health state valuations.
    Dolan P; Kind P
    Soc Sci Med; 1996 Feb; 42(4):609-15. PubMed ID: 8643985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.